会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 151. 发明申请
    • PROCESS FOR THE PREPARATION OF SUBSTITUTED 5-HYDROXY-OXAZOLIDIN-4-ONE
    • 制备取代的5-羟基 - 恶唑烷-4-酮的方法
    • WO1996037483A1
    • 1996-11-28
    • PCT/GB1996001149
    • 1996-05-13
    • ZENECA LIMITEDCOX, John, MichaelPEARSON, David, Philip, JohnKOZAKIEWICZ, Anthony, MarianMOORE, Richard, ButlerMITCHELL, GlynnLANGTON, David, WilliamELLIS, Russel, Martin
    • ZENECA LIMITED
    • C07D263/18
    • C07D263/18C07D263/28
    • A process for the synthesis of a compound of general formula (II), wherein: R and R are each independently hydrogen or C1-C4 alkyl; A is an aromatic or heteroaromatic ring system optionally substituted with one or more substituents selected from: halogen or C1-C10 hydrocarbyl, -O(C1-C10 hydrocarbyl), -S(C1-C10 hydrocarbyl), -SO(C1-C10 hydrocarbyl) or -SO2(C1-C10 hydrocarbyl), cyano, nitro, SCN, SiR 3 (where each R is independently C1-C4 alkyl or phenyl), COR , CR NOR , NHOH, ONR R , SF5, COOR , SO2NR R , OR or NR R ; and in which any ring nitrogen atom may be quaternised or oxidised; alternatively, any two substituents of the group A may combine to form a fused 5- or 6-membered saturated or partially saturated carbocyclic or heterocyclic ring in which any carbon or quaternised nitrogen atom may be substituted with any of the groups mentioned above for A or in which a ring carbon atom may be oxidised; R and R are each independently hydrogen or C1-C10 hydrocarbyl; R is hydrogen, C1-C10 hydrocarbyl, SO2(C1-C10 hydrocarbyl), CHO, CO(C1-C10 hydrocarbyl), COO(C1-C10 hydrocarbyl) or CONR R ; R and R are each independently hydrogen, C1-C10 hydrocarbyl, O(C1-C10 hydrocarbyl), SO2(C1-C10 hydrocarbyl), CHO, CO(C1-C10 hydrocarbyl), COO(C1-C10 hydrocarbyl) or CONR R ; any of the hydrocarbyl groups within the group A may optionally be substituted with halogen (i.e. chlorine, bromine, fluorine or iodine), hydroxy, SO2NR R (where R and R are independently H or C1-C6 alkyl), cyano, nitro, amino, mono- and dialkylamino in which the alkyl groups have from 1 to 6 or more carbon atoms, acylamino, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 alkylsulphinyl, C1-C6 alkylsulphonyl, carboxy, carboxyamide, in which the groups attached to the N atom may be hydrogen or lower hydrocarbyl optionally substituted with halogen; alkoxy carbonyl wherein the alkoxy group may have from 1 to 6 or more carbon atoms, or aryl such as phenyl; the process comprising cyclising a compound of general formula (VII); wherein A, R and R are as defined for general formula (II), R is hydrogen, benzyl or benzyl substituted with up to five substituents selected from halo, C1-C6 alkyl, O(C1-C6 alkyl) or nitro and R is C1-C8 alkyl, benzyl or benzyl substituted with up to five of the substituents mentioned above for R .
    • 一种合成通式(II)化合物的方法,其中:R 2和R 3各自独立地为氢或C 1 -C 4烷基; A是任选被一个或多个选自以下的取代基取代的芳族或杂芳族环系:卤素或C 1 -C 10烃基,-O(C 1 -C 10烃基),-S(C 1 -C 10烃基), - (C 1 -C 10烃基 )或-SO 2(C 1 -C 10烃基),氰基,硝基,SCN,SiR c 3(其中每个R c独立地为C 1 -C 4烷基或苯基),COR 7, 8,NHOH,ONR 7 R 8,SF 5,COOR 7,SO 2 NR 7 R 8,OR 9或NR 10 R 11; 并且其中任何环氮原子可被季铵化或氧化; 可选地,基团A的任何两个取代基可以结合形成稠合的5或6元饱和或部分饱和的碳环或杂环,其中任何碳或季铵化的氮原子可被上述任何A或 其中环碳原子可被氧化; R 7和R 8各自独立地为氢或C 1 -C 10烃基; R 9是氢,C 1 -C 10烃基,SO 2(C 1 -C 10烃基),CHO,CO(C 1 -C 10烃基),COO(C 1 -C 10烃基)或CONR 7 R 8; R 10和R 11各自独立地为氢,C 1 -C 10烃基,O(C 1 -C 10烃基),SO 2(C 1 -C 10烃基),CHO,CO(C 1 -C 10烃基) 烃基)或CONR 7 R 8; 基团A中的任何烃基可以任选地被卤素(即氯,溴,氟或碘),羟基,SO 2 NR a R b(其中R a和R b独立地是H 或C 1 -C 6烷基),氰基,硝基,氨基,一烷基氨基和二烷基氨基,其中烷基具有1至6个或更多个碳原子,酰基氨基,C 1 -C 6烷氧基,C 1 -C 6卤代烷氧基,C 1 -C 6烷硫基,C 1 -C 6烷基亚磺酰基,C 1 -C 6烷基磺酰基,羧基,羧酰胺,其中与N原子连接的基团可以是氢或任选被卤素取代的低级烃基; 烷氧基羰基,其中烷氧基可以具有1至6个或更多个碳原子,或芳基如苯基; 该方法包括环化通式(VII)的化合物; 其中A,R 2和R 3如通式(II)所定义,R 20是氢,被至多5个选自卤素,C 1 -C 6烷基,O(C 1 -C 6) -C 1-6烷基)或硝基,R 21是C 1 -C 8烷基,被至多五个上述R 20取代基取代的苄基或苄基。
    • 153. 发明申请
    • INK JET PRINTING INK
    • 喷墨打印墨水
    • WO1996034919A1
    • 1996-11-07
    • PCT/GB1996000995
    • 1996-04-26
    • ZENECA LIMITEDGUNN, JanetHOLBROOK, MarkLAVERY, Aidan, Joseph
    • ZENECA LIMITED
    • C09D11/00
    • C09D11/38
    • Ink compositions comprising an aqueous medium containing: (1) at least one water-soluble dye; (2) at least one cyclic ester or amide of formula (1), wherein m is a whole number from 3 to 5 and X represents -O- or -N(R)- in which R represents hydrogen, alkyl or substituted alkyl; (3) at least one hydroxy compound selected from polyhydroxy compounds having at least four hydroxy groups, optionally substituted cycloalkanols, cyclohexane dimethanol, benzyl alcohol, benzene dimethanol, phenol and polyhydroxybenzenes, and (4) at least one water-soluble organic solvent selected from alkanediols, alkanetriols, ether glycols and thioether glycols and suitable for use in ink jet printing processes for coloration of substrates such as paper or overhead projector slides.
    • 包含水性介质的油墨组合物含有:(1)至少一种水溶性染料; (2)至少一种式(1)的环酯或酰胺,其中m是3至5的整数,X表示-O-或-N(R) - ,其中R表示氢,烷基或取代的烷基; (3)选自具有至少四个羟基的多羟基化合物,任选取代的环烷醇,环己烷二甲醇,苄醇,苯二甲醇,苯酚和多羟基苯的至少一种羟基化合物,和(4)至少一种选自以下的水溶性有机溶剂: 链烷二醇,烷三醇,醚二醇和硫醚二醇,适用于喷墨印刷工艺,用于着色诸如纸或高架投影仪载玻片的基材。
    • 154. 发明申请
    • QUINAZOLINE DERIVATIVES
    • 喹诺酮衍生物
    • WO1996033980A1
    • 1996-10-31
    • PCT/GB1996000961
    • 1996-04-23
    • ZENECA LIMITEDGIBSON, Keith, Hopkinson
    • ZENECA LIMITED
    • C07D239/94
    • C07D403/12C07D239/94
    • The invention concerns quinazoline derivatives of the formula (I) wherein n is 1, 2 or 3 and each R is independently halogeno, trifluoromethyl or (1-4C)alkyl; R is (1-4C)alkoxy; and R is di-[(1-4C)alkyl]amino-(2-4C)alkoxy, pyrrolidin-1-yl-(2-4C)alkoxy, piperidino-(2-4C)alkoxy, morpholino-(2-4C)alkoxy, piperazin-1-yl-(2-4C)alkoxy, 4-(1-4C)alkylpiperazin-1-yl-(2-4C)alkoxy, imidazol-1-yl-(2-4C)alkoxy, di-[(1-4C)alkoxy-(2-4C)alkoxyl]amino-(2-4C)alkoxy, thiamorpholino-(2-4C)alkoxy, 1-oxothiamorpholino-(2-4C)alkoxy or 1,1-dioxothiamorpholino-(2-4C)alkoxy, and wherein any of the above-mentioned R substituents comprising a CH2 (methylene) group which is not attached to a N or O atom optionally bears on said CH2 group a hydroxy substituent; or pharmaceutically-acceptable salts thereof; processes for their preparation, pharmaceutical compositions containing them, and the use of the receptor tyrosine kinase inhibitory properties of the compounds in the treatment of proliferative disease such as cancer.
    • 本发明涉及式(I)的喹唑啉衍生物,其中n为1,2或3,并且每个R 2独立地为卤代,三氟甲基或(1-4C)烷基; R 3为(1-4C)烷氧基; 并且R 1是二 - [(1-4C)烷基]氨基 - (2-4C)烷氧基,吡咯烷-1-基 - (2-4C)烷氧基,哌啶子基 - (2-4C)烷氧基,吗啉代 2-4C)烷氧基,哌嗪-1-基 - (2-4C)烷氧基,4-(1-4C)烷基哌嗪-1-基 - (2-4C)烷氧基,咪唑-1-基 - (2-4C) 烷氧基,二 - [(1-4C)烷氧基 - (2-4C)烷氧基]氨基 - (2-4C)烷氧基,硫代吗啉代 - (2-4C)烷氧基,1-氧硫代吗啉代 - (2-4C) (2-4C)烷氧基,并且其中包含未连接到N或O原子上的CH2(亚甲基)基团的任何上述R 1取代基任选地在所述CH 2基团上带有羟基取代基 ; 或其药学上可接受的盐; 其制备方法,含有它们的药物组合物以及该化合物的受体酪氨酸激酶抑制性质用于治疗增殖性疾病例如癌症的用途。
    • 159. 发明申请
    • LIQUID PHOTOCURABLE COMPOSITIONS
    • 液体光电组合物
    • WO1996028762A1
    • 1996-09-19
    • PCT/GB1996000517
    • 1996-03-06
    • ZENECA LIMITEDPOPAT, Ajay, HaridasLAWSON, John, RobertMCLEAN, Colin, Henry
    • ZENECA LIMITED
    • G03F07/027
    • G03F7/0037G03F7/027
    • A liquid composition comprising: a) 5 to 25 parts of a monomeric aliphatic or cycloaliphatic di(meth)acrylate having a MW of not more than 800; b) 2 to 20 parts of a monomeric poly(meth)acrylate having a functionality of at least 3 and a MW of at least 610; c) 12 to 40 parts of a urethane(meth)acrylate having a functionality of 2 to 4 and a MW of 400 to 10,000; d) 35 to 70 parts of a monomeric or oligomeric di(meth)acrylate based on bisphenol A or bisphenol F; and e) 0.1 to 10 parts of a photoinitiator; wherein all parts are by weight, the total number of parts of a) + b) does not exceed 30 and the total number of parts of a) + b) + c) + d) + e) add up to 100. The compositions are suitable for the stereolighographic production of three-dimensional solid articles such as mechanical parts and models of body parts.
    • 一种液体组合物,其包含:a)5〜25份MW不大于800的单体脂族或脂环族二(甲基)丙烯酸酯; b)2至20份官能度至少为3且MW至少为610的单体聚(甲基)丙烯酸酯; c)12〜40份官能度为2〜4,MW为400〜10,000的氨基甲酸酯(甲基)丙烯酸酯; d)35〜70份基于双酚A或双酚F的单体或低聚二(甲基)丙烯酸酯; 和e)0.1至10份光引发剂; 其中所有部分都是重量比,a)+ b)的部分总数不超过30,a)+ b)+ c)+ d)+ e)的总数量加到100上。组合物 适用于三维固体制品如机械零件和车身部件型号的立体定向生产。